Daniel George, MD

Internationally recognized clinical researcher and thought leader in prostate cancer and renal cell carcinoma, with over 100 peer-reviewed publications in genitourinary oncology. His areas of research include new drug development and biomarkers of GU cancers with an emphasis on signal transduction pathways and angiogenesis.

Nationally, is the Duke principal investigator for the Department of Defense sponsored prostate cancer clinical trials consortium grant since 2006. He has also served as